Biology and Life Sciences

Biology and Life Sciences

African sleeping sickness; Causes and Treatments

Pages: 6  ,  Volume: 28  ,  Issue: 1 , May   2019
Received: 19 May 2019  ,  Published: 13 June 2019
Views: 47  ,  Download: 0

Authors

# Author Name
1 Haleema Sadia
2 Asif Naeem
3 Abdul Majeed
4 Ayesha Alam
5 Shahid Raza

Abstract

Among many diseases; African sleeping sickness is a tropical disease which is result of the bite of tse.tse fly where parasitic protozoans (trypanosomes) are transmitted. Early symptoms of this disease are fever, limbs pain, anemia and chills. It affects the nervous system seriously even sometimes causing death. Four drugs are used to treat Human African Trypanosomiasis (HAT). I.e, Suramin, Pentamidine, Melarsoprol and Eflornithine. First half of the 20th century was very important for the development of first three mentioned drugs, later on modern technology is discovering more innovative drugs for treatment of Sleeping Sickness. This article reviews about the stages, diagnosis and treatments of African sleeping sickness in living organisms.

Keywords

References

  1. Alirol E, Schrumpf D, Amici Heradi J, Riedel A, de Patoul C, Quere M, and Chappuis F (2012). Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Medecins Sans Frontieres experience in the Democratic Republic of the Congo. Clinical infectious diseases, 56(2), 195-203.
  2. Stijlemans B, De Baetselier P, Magez S, Van Ginderachter JA, and De Trez, C (2018). African trypanosomiasis-associated anemia: the contribution of the interplay between parasites and the mononuclear phagocyte system. Frontiers in Immunology, 9, 218.
  3. Chappuis F, Stivanello E, Adams K, Kidane S, Pittet A, and Bovier PA (2004). Card agglutination test for trypanosomiasis (CATT) end-dilution titer and cerebrospinal fluid cell count as predictors of human African Trypanosomiasis (Trypanosoma brucei gambiense) among serologically suspected individuals in southern Sudan. The American journal of tropical medicine and hygiene, 71(3), 313-317.
  4. Franco JR, Cecchi G, Priotto G, Paone M, Diarra A, Grout L, ... and Argaw D (2017). Monitoring the elimination of human African trypanosomiasis: update to 2014. PLoS neglected tropical diseases, 11(5), e0005585.
  5. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, ... and AlMazroa MA (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. The lancet, 380(9859), 2095-2128.
  6. Njiokou F, Laveissière C, Simo G, Nkinin S, Grébaut P, Cuny G, and Herder S (2006). Wild fauna as a probable animal reservoir for Trypanosoma brucei gambiense in Cameroon. Infection, genetics and evolution, 6(2), 147-153.
  7. Okagbue HI, Edeki SO, and Opanuga AA (2016). Correspondence analysis for the trend of human African trypanosomiasis. Research Journal of Applied Sciences, Engineering and Technology, 448-453.
  8. Varmus H, Klausner R, Zerhouni E, Acharya T, Daar AS, and Singer PA (2003). Grand challenges in global health.
  9. World Health Organization (2000). The world health report 2000: health systems: improving performance. World Health Organization.